Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease.
about
A Brief Overview of Tauopathy: Causes, Consequences, and Therapeutic Strategies.The Emerging Role of GLP-1 Receptors in DNA Repair: Implications in Neurological Disorders.Tackling dipeptidyl peptidase IV in neurological disorders.Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin.The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway.
P2860
Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Linagliptin, a Dipeptidyl Pept ...... Model of Alzheimer's Disease.
@en
Linagliptin, a Dipeptidyl Pept ...... Model of Alzheimer's Disease.
@nl
type
label
Linagliptin, a Dipeptidyl Pept ...... Model of Alzheimer's Disease.
@en
Linagliptin, a Dipeptidyl Pept ...... Model of Alzheimer's Disease.
@nl
prefLabel
Linagliptin, a Dipeptidyl Pept ...... Model of Alzheimer's Disease.
@en
Linagliptin, a Dipeptidyl Pept ...... Model of Alzheimer's Disease.
@nl
P2860
P50
P1476
Linagliptin, a Dipeptidyl Pept ...... e Model of Alzheimer's Disease
@en
P2093
P2860
P2888
P304
P356
10.1007/S12035-016-0125-7
P577
2016-10-03T00:00:00Z